Skip to main content

Corona Impact: Is Digital Health Market will Propel at a Defining Pace 2020

  

The emergency of coronavirus has made a favorable impact on the global digital health market growth in 2020. During the emergency, COVID-19 has put the healthcare industry at a stage of rapid demand for telemedicine, online consultation and remote patient engagement for effective communication between doctors and patients. Also, increasing importance of home healthcare services is directly affecting the demand for digital health services owing to increasing consciousness among the people about the wide spread of the novel coronavirus. These factors are estimated to drive the market growth in the emergency time. Moreover, some of the government bodies are taking several activities to help the enterprises to endure in the crisis. For example, in recent times, the Infocomm Media Development Authority and Enterprise Singapore expanded the digitalization support for education and healthcare SMEs to manage the effect of the coronavirus. The learning management systems and tele-consultation solutions plan to offer education & healthcare providers to provide their services remotely. During this crisis, our analysts provide market players support in understanding the effect of COVID19 on the digital health market.

According to new study done by Research Dive, the global digital health market is expected to reach up to $1,045.8 million by 2027 and rising at a CAGR of 33.4% during the estimated time from 2020-2027. The global market is classified into technology, component and region. This study delivers comprehensive insights about drivers, opportunities, restraints, segmentation and top market players in the global market.

Factors affecting the market growth

As per our analysts, increasing trend for incorporation of artificial intelligence, internet of things and big data analytics to advance the digital healthcare is major driving factor for the growth of the market in the forecast years. However, huge implementation costs of the digital health services is predicted to be major restraint for the market growth.

Digital health systems technology and hardware segments held the global market size in previous decades-

Based on technology, the global market has been segmented into telehealthcare, health analytics, mHealth and digital health systems. Among these, digital health systems segment accounted for highest market size in 2019, it was valued at $52.7 billion and is estimated to rise at a healthy rate of 32.9% CAGR in the projected time. This dominance is majorly owing to growing government investments to promote digital health, which will drive the demand for digital health systems. Besides digital health systems, health analytics segment will witness to rise at a faster rate of 34.2% CAGR and is predicted to experience a potential growth in the forecast period.

The global digital health market has been categorized on the basis on component into software, services and hardware. In these, hardware segment generated majority of the digital health market share in the previous years, which was 38.0% and is predicted to account for $366.0 million by the end of 2027. This growth is due to rising geriatric population across the globe is expected to drive the demand for wearable medical devices like ECG monitors, BP monitors and fitness trackers. This factor will propel the market growth in the forecast time period. Services component is expected to grow at a significant rate of 33.9% CAGR during the forecast years. Increasing investments to improve healthcare digital infrastructures in the developed and developing economies is estimated to drive requirement of services to provide most efficient digital platforms.

Digital health market, Regional analysis

In 2019, the global digital health market has commanded by North America region and is predicted to generate a revenue of $360.8 million by the end of 2027. Wide utilization of digital health services across the North America due to swift growth in adoption of smart mobiles along with developments in coverage network systems. This factor is estimated to impel the market growth in the review period. Besides North America, Asia-Pacific will witness to grow at a faster rate of 34.2% CAGR in the forecast years and is predicted to create huge opportunities for market growth in the coming decades. This predicted rise credited to favorable government initiatives to support advancements in healthcare IT and increasing adoption of mHealth services across the Asia-Pacific region.

Top 10 Prominent players operating in the Global Digital Health Market include-

1. Allscripts Healthcare, LLC
2. CISCO
3. McKesson Corporation
4. AirStrip
5. Google Inc.
6. Koninklijke Philips N.V.
7. BioTelemetry, Inc.
8. Honeywell International Inc.
9. Cerner Corporation
10. Telefónica S.A.

Reference: https://www.researchdive.com/press-release/digital-health-market.html

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Popular posts from this blog

How COVID-19 Pandemic Will Impact on Organ Care System Market For Lungs Growth in 2020 and Coming Future?

   The spread of the COVID-19 pandemic has brought a positive impact on the global organ care system for the lungs industry. Lung transplantation is still witnessing newer heights in the global market. Key players are highlighting mainly on the newer and innovative business strategies to strengthen the footprint in the market during and post-pandemic period. The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global organ care system for lungs industry. This is professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak. Download FREE Sample at:   https://www.researchdive.com/download-sample/341 Highlights of the Report: The market is anticipated to perceive growth owing to the mounting demand for

Why Dynamics of Laboratory Temperature Control Units Market Is Changing Drastically? What If History Is Any Guide?

   The worldwide spread of COVID-19 has positively impacted the global laboratory temperature control units market. This is mainly because various market players are taking initiatives to such as new innovations and novel technologies to fight the challenges created by COVID-19 outbreak. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to increasing adoption of laboratory temperature control units in the various industries such as pharmaceuticals, food & beverages, and cosmetics. The  global laboratory temperature control units market  is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global laboratory temperature control units market is anticipated to reach up to $833.83 million during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by major ma

How COVID-19 Pandemic Will Impact on Pneumonia Therapeutics Market Growth and Demand in 2020 and Coming Future?

   The pneumonia therapeutics market is predicted to have a positive impact in 2020. Increasing cases of pneumococcal disease is predicted to drive the market in the forecast period. Pneumonia is mostly caused due to the infection in the lungs. At present the symptoms of coronavirus are most similar to that of pneumonia due to which most of the companies are focusing more on their research and development activities to launch new products to treat both the deadly diseases. For instance, in July 2020 NABRIVA received European approval for XENLETA (lefamulin) for treatment of community-acquired pneumonia (CAP). XENLETA is the first new antibiotic approved for patients with CAP in Europe. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market. According to a study conducted by Research Dive,  the global pneumonia therapeutics market is expected to register a revenue of $3,147.7 million till 2027, growing at a rate of 8.2%